Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells

Journal of General Virology

Volumn 88, Issue 2, 2007, Pages 365-375

  Chareonsirisuthigul, Takol ^a   Kalayanarooj, Siripen ^b   Ubol, Sukathida ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NITRIC OXIDE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY; VIRUS RNA;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; CYTOKINES; DENGUE VIRUS; DOWN-REGULATION; FREE RADICALS; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRUS REPLICATION;

DENGUE VIRUS;

EID: 33846805819     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82537-0     Document Type: Article

References (50)

1. Akaike, T. & Maeda, H. (2000). Nitric oxide and virus infection. Immunology 101, 300-308.
2. Akerstrom, S., Mousavi-Jazi, M., Klingstrom, J., Lelion, M., Lundkvist, A. & Mirazimi, A. (2005). Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol 79, 1966-1969.
3. Alleva, D. G., Johnson, E. B., Lio, F. M., Boehme, S. A., Conlon, P. J. & Crowe, P. D. (2002). Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J Leukoc Biol 71, 677-685.
4. Atrasheuskaya, A., Petzelbauer, P., Fredeking, T. M. & Ignatyev, G. (2003). Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 35, 33-42.
5. Bashyam, H. S., Green, S. & Rothman, A. L. (2006). Dengue virus- reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 176, 2817-2824.
6. Benz, D., Cadet, P., Mantione, K., Zhu, W. & Stefano, G. (2002). Tonal nitric oxide and health: anti-bacterial and -viral actions and implications for HIV. Med Sci Monit 8, RA27-RA31.
7. Berlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A. & Bazzoni, F. (2002). Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 168, 6404-6411.
8. Bogdan, C. (2001). Nitric oxide and the immune response. Nat Immunol 2, 907-916.
9. Butrapet, S., Huang, C. Y., Pierro, D. J., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2000). Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins I and 3. J Virol 74, 3011-3019.
10. Cao, W., Baniecki, M. L., McGrath, W. J., Bao, C., Deming, C. B., Rade, J. J., Lowenstein, C. J. & Mangel, W. F. (2003). Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo. FASEB J 17, 2345-2346.
11. Charnsilpa, W., Takhampunya, R., Endy, T. P., Mammen, M. P., Jr, Libraty, D. H. & Ubol, S. (2005). Nitric oxide radicals suppress replication of wild-type dengue 2 viruses in vitro. J Med Virol 77, 89-95.
12. Chaturvedi, U. C., Agarwal, R., Elbishbishi, E. A. & Mustafa, A. S. (2000). Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28, 183-188.
13. Chen, Y. C., Wang, S. Y. & King, C. C. (1999). Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14- dependent mechanism. J Virol 73, 2650-2657.
14. Chen, L. C., Lei, H. Y., Liu, C. C., Shiesh, S. C., Chen, S. H., Liu, H. S., Lin, Y. S., Wang, S. T., Shyu, H. W. & Yeh, T. M. (2006). Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74, 142-147.
15. da Fonseca, B. A. & Fonseca, S. N. (2002). Dengue virus infections. Curr Opin Pediatr 14, 67-71.
16. Gubler, D. J. (1998). Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11, 480-496.
17. Ho, L. J., Hung, L. F., Weng, C. Y., Wu, W. L., Chou, P., Lin, Y. L., Chang, D. M., Tai, T. Y. & Lai, J. H. (2005). Dengue virus type 2 antagonizes IFN-α but not IFN-γ antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174, 8163-8172.
18. Houng, H. H., Hritz, D. & Kanesa-thasan, N. (2000). Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on 3′- noncoding sequence. J Virol Methods 86, 1-11.
19. Jarasch, N., Martin, U., Kamphausen, E., Zell, R., Wutzler, P. & Henke, A. (2005). Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. Viral Immunol 18, 355-364.
20. Jindadamrongwech, S., Thepparit, C. & Smith, D. R. (2004). Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 149, 915-927.
21. Kliks, S. C., Nimmanitya, S., Nisalak, A. & Burke, D. S. (1988). Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38, 411-419.
22. Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L. & Burke, D. S. (1989). Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40, 444-451.
23. Klimstra, W. B., Williams, J. C., Ryman, K. D. & Heidner, H. W. (2005). Targeting Sindbis virus-based vectors to Fc receptor-positive cell types. Virology 338, 9-21.
24. Kuno, G., Gomez, I. & Gubler, D. J. (1991). An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 33, 101-113.
25. Lanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J. & Vorndam, A. V. (1992). Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30, 545-551.
26. Lei, H. Y., Yeh, T. M., Liu, H. S., Lin, Y. S., Chen, S. H. & Liu, C. C. (2001). Immunopathogenesis of dengue virus infection. J Biomed Sci 8, 377-388.
27. Ligon, B. L. (2005). Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. Semin Pediatr Infect Dis 16, 60-65.
28. Lin, C. F., Lei, H. Y., Shiau, A. L., Liu, H. S., Yeh, T. M., Chen, S. H., Liu, C. C, Chiu, S. C. & Lin, Y. S. (2002). Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. j Immunol 169, 657-664.
29. Mahalingam, S. & Lidbury, B. A. (2002). Suppression of lipopoly- saccharide-induced antiviral transcription factor (STAT-1 and NF- kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc Natl Acad Sci U S A 99, 13819-13824.
30. Matsuura, M., Saito, S., Hirai, Y. & Okamura, H. (2003). A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells. Eur J Biochem 270, 4016-4025.
31. Mongkolsapaya, J., Dejniraftisal, W., Xu, X. N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivom, S., Duangchinda, T., Dong, T. & other authors (2003). Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9, 921-927.
32. Morens, D. M. & Halstead, S. B. (1990). Measurement of antibody- dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 71, 2909-2914.
33. Munoz-Jordan, J. L., Laurent-Rolle, M., Ashour, J., Martinez- Sobrido, L., Ashok, M., Lipkin, W. 1. & Garcia-Sastre, A. (2005). inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79, 8004-8013.
34. Nguyen, T. H., Lei, H. Y., Nguyen, T. L., Lin, Y. S., Huang, K. J., Le, B. L., Lin, C. F., Yeh, T. M., Do, Q. H. & other authors (2004). Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189, 221-232.
35. Raghupathy, R., Chaturvedi, U. C., Al-Sayer, H., Elbishbishi, E. A., Agarwal, R., Nagar, R., Kapoor, S., Misra, A., Mathur, A. & other authors (1998). Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56, 280-285.
36. Reyes-Del Valle, J., Chavez-Salinas, S., Medina, F. & Del Angel, R. M. (2005). Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79,4557-4567.
37. Rothman, A. L. (2003). Immunology and immunopathogenesis of dengue disease. Adv Virus Res 60, 397-419.
38. Rothman, A. L. (2004). Dengue: defining protective versus pathologic immunity. J Clin Invest 113, 946-951.
39. Rulli, N. E., Suhrbier, A., Hueston, L., Heise, M. T., Tupanceska, D., Zaid, A., Wilmes, A., Gilmore, K., Lidbury, B. A. & Mahalingam, S. (2005). Ross River virus: molecular and cellular aspects of disease pathogenesis. Pharmacol Ther 107, 329-342.
40. Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R. & Harris, E. (2004). Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78, 2701-2710.
41. Sosroseno, W., Barid, L, Herminajeng, E. & Susilowati, H. (2002). Nitric oxide production by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actino-bacillus actinomycetemcomitans. Oral Microbiol Immunol 17, 72-78.
42. Sullivan, N. J. (2001). Antibody-mediated enhancement of viral disease. Curr Top Microbiol Immunol 260, 145-169.
43. Takhampunya, R., Padmanabhan, R. & Ubol, S. (2006). Antiviral action of nitric oxide on dengue virus type 2 replication. J Gen Virol 87, 3003-3011.
44. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S. & other authors (2003)..DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. I Exp Med 197, 823-829.
45. Trischmann, H., Davis, D. & Lachmann, P. J. (1995). Lympho-cytotropic strains of HfV type I when complexed with enhancing antibodies can infect macrophages via Fc gamma RIII, independently of CD4. AIDS Res Hum Retroviruses 11, 343-352.
46. Ubol, S., Sukwattanapan, C. & Utaisincharoen, P. (1998). Rabies virus replication induces Bax-related, caspase dependent apoptosis in mouse neuroblastoma cells. Virus Res 56, 207-215.
47. Utaisincharoen, P., Anuntagool, N., Arjcharoen, S., Limposuwan, K., Chaisuriya, P. & Sirisinha, S. (2004). Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macro- phages. Clin Exp Immunol 136, 277-283.
48. Valero, N., Espina, L. M., Anez, G., Torres, E. & Mosquera, J. A. (2002). Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 66, 762-764.
49. Wu, S. J., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Fligueira, L., Marovich, M. A. & other authors (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6, 816-820.
50. Yang, K. D., Yeh, W. T., Yang, M. Y., Chen, R. F. & Shaio, M. F. (2001). Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol 63, 150-157.